Health-Related Quality of Life as Measured by the 36-Item Short Form Survey Among Adults With Acute Bacterial Skin and Skin Structure Infections who Received Either Omadacycline or Linezolid in a Phase 3 Double-Blind, Double-Dummy Clinical Trial

Abstract This analysis of data from a Phase 3 study of adults with acute bacterial skin and skin structure infections showed that successful oral treatment with omadacycline (n = 368) or linezolid (n = 367) was associated with improvement in health-related quality of life.

Saved in:

Bibliographic Details
Published in:	Open forum infectious diseases Vol. 8; no. 10; p. ofab459
Main Authors:	Chitra, Surya, Hinahara, Jordan, Goss, Thomas F, Gunter, Kyle, LaPensee, Kenneth
Format:	Journal Article
Language:	English
Published:	US Oxford University Press 01-10-2021
Subjects:	Brief Reports omadacycline ABSSSI acute bacterial skin and skin structure infections quality of life patient-reported outcome measures
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Abstract This analysis of data from a Phase 3 study of adults with acute bacterial skin and skin structure infections showed that successful oral treatment with omadacycline (n = 368) or linezolid (n = 367) was associated with improvement in health-related quality of life.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	2328-8957 2328-8957
DOI:	10.1093/ofid/ofab459